ENANTA PHARMACEUTICALS INC
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
ENTA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 4 KINGSBURY AVENUE, 2472 WATERTOWN
- Website:
- https://www.enanta.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Enanta Pharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs, with an emphasis on virology and immunology. The company utilizes a robust, chemistry-driven approach to create therapeutics for diseases with high unmet medical needs. Enanta has a proven track record, having developed drugs for combination regimens that have cured over one million people with chronic hepatitis C virus (HCV) infection. Its current development pipeline includes candidates for the treatment of Respiratory Syncytial Virus (RSV) and other immunological diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ENANTA PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ENANTA PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ENANTA PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
